NNOX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NNOX is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading weakly at 1.31 with bearish trend structure, no proprietary buy signal, and multiple lawsuit headlines creating a clear negative sentiment backdrop. While analysts still keep a Buy rating and a $5 target, the current price action and event risk do not support an immediate purchase.
The technical picture is bearish. MACD histogram is below zero at -0.0278 and still negative, RSI_6 is neutral at 45.44, and moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5. Price is sitting near the pivot at 1.292, with resistance at 1.701 and 1.954 above, while support is at 0.883 and 0.63 below. This setup suggests the stock is in a weak downtrend with no confirmed reversal. The short-term pattern data also shows only a modest 40% chance of a 1.5% gain next day and a negative expected move over the next month.
Analysts at Alliance Global kept a Buy rating and said Q4 results were in line with expectations. Management also maintained 2026 revenue guidance, which implies a potential turnaround if execution improves. The company also highlighted recent distribution agreements, which could support future revenue growth. Options data is also strongly call-skewed, indicating some bullish trader sentiment.
Multiple class action lawsuits were filed on July 1-2, 2026, alleging misleading statements, operational cost issues, and securities law violations. The news flow also points to a reported Q4 net loss of $33.4 million and a sharp stock price drop following the CFO resignation announcement. Technically, the stock remains in a bearish trend, and both AI Stock Picker and SwingMax show no signal today. Insider and hedge fund activity is neutral, and there is no congress trading support.
Latest quarter: Q4 2025. The available financial commentary says results were in line with expectations, but the company still reported a net loss of $33.4 million. Management maintained 2026 revenue guidance, which is a constructive sign for future growth, but the latest quarter does not yet show strong fundamental profitability improvement.
The recent analyst trend is mixed-to-cautious bullish: Alliance Global lowered its price target from $7 to $5 but kept a Buy rating. The pros view is that Q4 was in line, guidance was maintained, and distribution agreements could help future growth. The cons view is that the target cut signals reduced confidence, and analysts are still waiting for clearer execution before becoming more aggressive.
